Silo Pharma Announces Positive Results from IND-Enabling

Silo Pharma Announces Positive Results from IND-Enabling

ENGLEWOOD CLIFFS, NJ, March 15, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical......

menu
menu